BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
It's such a great question. And I think there's a lot of effort right now ongoing to try to understand the role of biomarkers, specifically ctDNA, and how we can incorporate them prospectively and better select the patients that actually need therapy. So as medical oncologists, we intensify treatment a lot because we want to
0
💬
0
Comments
Log in to comment.
There are no comments yet.